Authors:
Campone, M
Fumoleau, P
Delecroix, V
Deporte-Fety, R
Perrocheau, G
Vernillet, L
Borg-Olivier, O
Louboutin, JP
Bissery, MC
Riva, A
Azli, N
Citation: M. Campone et al., Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer, ANN ONCOL, 12(7), 2001, pp. 909-918
Authors:
Adenis, A
Bonneterre, J
Bonneterre, ME
Pion, JM
Vanlemmens, L
Gladieff, L
de Lafontan, B
Martel, P
Mihura, J
Roche, H
Gedouin, D
Kerbrat, P
Lesimple, T
Bremond, A
Devaux, Y
Delecroix, V
Fumoleau, P
Maugard-Louboutin, C
Namer, M
Goudier, MJ
Morice, F
Montcuquet, P
Schraub, S
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Bastit, P
Chevallier, B
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Datchary, J
Audhuy, B
Barats, JC
Kohser, F
Dides, S
Ramos, R
Cattan, A
Eymard, JC
Pourny, C
Weber, B
de Laroche, G
Pichon, A
Seffert, P
Hayat, M
Zambon, E
Chollet, P
Van Praagh, I
Citation: A. Adenis et al., Benefit of a high-dose epirubicin regimen in adjuvant chemotherapy for node-positive breast cancer patients with poor prognostic factors: 5-year follow-up results of French adjuvant study group 05 randomized trial, J CL ONCOL, 19(3), 2001, pp. 602-611
Authors:
Bastit, P
Chevallier, B
Chevreau, C
Mihura, J
Roche, H
Namer, M
Gedouin, D
Kerbrat, P
Lesimple, T
Coudert, B
Fargeot, P
de Gislain, C
Mayer, F
Luporsi, E
Rios, M
Weber, B
Bremond, A
Devaux, Y
Monteuquet, P
Schraub, S
Hayat, M
Zambon, E
Grandgirard, A
Monnier, A
Sun, X
Clavere, P
Ollivier, JP
Rhein, B
Roullet, B
Chollet, P
Van Praagh, I
Cattan, A
Eymard, JC
Pourny, C
Facchini, T
Walter, S
Dides, S
Ramos, R
Guiochet, N
Seffert, P
Perpoint, X
Sztermer, JF
Cretin, J
Goudier, MJ
Morice, F
Delecroix, V
Fumoleau, P
Citation: P. Bastit et al., Epirubicin-based chemotherapy in metastatic breast cancer patients: Role of dose-intensity and duration of treatment, J CL ONCOL, 18(17), 2000, pp. 3115-3124
Citation: V. Delecroix, Kierkegaard: the deterioration of traditional philosophical language and the possibility of creating a new language, REV MET MOR, (2), 2000, pp. 163-177